2016年12月ACCA考试P5高级业绩管理真题及答案解析.doc
《2016年12月ACCA考试P5高级业绩管理真题及答案解析.doc》由会员分享,可在线阅读,更多相关《2016年12月ACCA考试P5高级业绩管理真题及答案解析.doc(31页珍藏版)》请在麦多课文档分享上搜索。
1、2016 年 12 月 ACCA 考试 P5 高级业绩管理真题及答案解析(总分:125.00,做题时间:195 分钟)案例分析题(总题数:4,分数:125.00)Section A This ONE question is compulsory and MUST be attemptedMonza Pharma (Monza) is a developer and manufacturer of medical drugs, based in Beeland but selling its products all over the world. As a listed company, th
2、e overall objective of the company is to maximise the return to shareholders and it has used return on capital employed (ROCE) as its performance measure for this objective. There has often been comment at board meetings that it is good to have one, easily-understood measure for consideration.The co
3、mpany has three divisions: the drug development division develops new drug compounds, taking these through the regulatory systems of different countries until they are approved for sale; the manufacturing division then makes these compounds; the sales division then sells them.Monzas share price has
4、underperformed compared to the market and the health sector in the last two years. The chief executive officer (CEO) has identified that its current performance measures are too narrow and is implementing a balanced scorecard (BSC) approach to address this problem. The current performance measures a
5、re: Return on capital employed Average cost to develop a new drug Revenue growthThe CEO engaged a well-known consulting firm who recommended the use of a BSC. The consultants began by agreeing with the board of Monza that the objective for the organisations medium-term strategy was as follows: Creat
6、e shareholder value by:Innovating in drug developmentEfficiency in drug manufacturingSuccess in selling their productsThe consulting firm has presented an interim report with the following proposed performance measures: Financial: ROCE Customer: Revenue growth Internal business process: Average cost
7、 to develop a new drug Learning and growth: Training days provided for employees each yearThe CEO and the lead consultant have had a disagreement about the quality and cost of this work and as a result the consultants have been dismissed. The CEO has commented that the proposed measures lack insight
8、 into the business and do not appear to tackle issues at strategic, tactical and operational levels.The CEO has decided to take this work in-house and has asked you as the performance management expert in the finance department to assist him by writing a report to the board to cover a number of area
9、s. First, following the disagreement with the consultants, the CEO is worried that the consultants may not have been clear about the problems of using the BSC in their rush to persuade Monza to use their services.Second, he wants you to evaluate the choice of performance measures currently used by M
10、onza and those proposed by the consulting firm.Third, there has been a debate at board level about how ROCE should be calculated. The marketing director stated that she was not sure what profit figure (of at least four which were available) should be used and why, especially given the large variatio
11、n in result which this gives. She also wondered what the effect would be of using equity rather than all capital to calculate a return on investment. Some basic data has been provided in Appendix 1 to assist you in quantifying and evaluating these possibilities.In addition to these concerns, the boa
12、rd is considering introducing a total quality management approach within Monza. Obviously, quality of output is critical in such a heavily regulated industry where the products can be a matter of life and death. There has been discussion about testing this idea within the manufacturing division. The
13、 CEO wants to understand, first, the costs associated with quality issues within that division. To aid your analysis, he has supplied some detailed information in Appendix 2. Next, the board requires an outline evaluation of how a total quality management (TQM) approach would fit within the manufact
14、uring division.Finally, the drug development divisional managers have been lobbying for a new information system which will assist their research chemists in identifying new drug compounds for testing. The new system will need to be capable of performing calculations and simulations which require hi
15、gh computational power and memory but will also need to have access to external data sources so that these scientists can keep up with developments in the field and identify new opportunities. The CEO is worried about the cost of such a new system and wants to know how it would fit within the existi
16、ng lean management approach within that division.Appendix 2Cost information for the manufacturing division for the most recent accounting period1. Batches rejected at factory valued at $17m which have a scrap value of $4m.2. Training of factory staff which cost $8m.3. Regulatory fines costing $5m (d
17、ue to drug compounds being outside the specified range of mix of chemical ingredients).4. Discounts given following customer complaints due to late delivery costing $22m.5. Factory product testing department cost $12m.6. Cost of raw materials was $1,008m.Required:(分数:50.00)Write a report to the boar
18、d of Monza to:(i) Assess the problems of using a balanced scorecard at Monza. (8 marks)(ii) Evaluate the choice of the current performance measures and the consulting firms proposed performance measures for Monza. (12 marks)(iii) Evaluate the effect of choosing different profit and capital measureme
19、nts for different measures of return on investment and recommend a suitable approach for Monza. (11 marks)(iv) Analyse the current quality costs in the manufacturing division and then briefly discuss how implementation of total quality management would affect the division. (10 marks)(v) Briefly advi
20、se on how the drug development division can aim to make the new information system lean. (5 marks)Professional marks will be awarded for the format, style and structure of the discussion of your answer. (4 marks)(分数:50.00)_Section B TWO questions ONLY to be attemptedFramiltone is a food manufacturer
21、 based in Ceeland, whose objective is to maximise shareholder wealth. Framiltone has two divisions: Dairy division and Luxury division. Framiltone began manufacturing dairy foods 20 years ago and Dairy division, representing 60% of total revenue, is still the larger of Framiltones two divisions.Dair
22、y divisionThis division manufactures cheeses and milk-based desserts. The market in Ceeland for these products is saturated, with little opportunity for growth. Dairy division has, however, agreed profitable fixed price agreements to supply all the major supermarket chains in Ceeland for the next th
23、ree years. The division has also agreed long-term fixed volume and price contracts with suppliers of milk, which is by far the most significant raw material used by the division.In contrast to Luxury division, Dairy division does not operate its own fleet of delivery vehicles, but instead subcontrac
24、ts this to a third party distribution company. The terms of the contract provide that the distribution company can pass on some increases in fuel costs to Framiltone. These increases are capped at 05% annually and are agreed prior to the finalisation of each years budget.Production volumes have show
- 1.请仔细阅读文档,确保文档完整性,对于不预览、不比对内容而直接下载带来的问题本站不予受理。
- 2.下载的文档,不会出现我们的网址水印。
- 3、该文档所得收入(下载+内容+预览)归上传者、原创作者;如果您是本文档原作者,请点此认领!既往收益都归您。
下载文档到电脑,查找使用更方便
5000 积分 0人已下载
下载 | 加入VIP,交流精品资源 |
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 2016 12 ACCA 考试 P5 高级 业绩 管理 答案 解析 DOC
